Oxford Pharmaceuticals, LLC Email Format

Pharmaceutical ManufacturingAlabama, United States11-50 Employees

Oxford Pharmaceuticals, LLC operates as a manufacturer of generic oral solid tablets based in Birmingham, Alabama. The company runs a newly built facility covering 150,000 square feet, which received FDA approval in 2019, with emphasis on engineering, quality control, and process development supported by regulatory science to ensure product quality, safety, and efficacy. Its manufacturing and packaging operations are designed for large-scale production of oral solid dose forms and include automated packaging serialization aligned with 2023 requirements, along with substantial warehousing and security for finished products and controlled substances.

Oxford is developing a portfolio of more than 30 generic products and leverages an in-house distribution channel to provide consistent supply at competitive prices. The company began construction of its Birmingham facility in 2015, opened in 2016, and received FDA approval in 2019, with the first product approvals occurring that year and ongoing product launches since the pandemic began. The plant sits on a 27-acre site and is privately owned, with roots connected to a UK investor and CEO.

Sign up for free to view info

Company overview Employee directory